Treatment with Insulin Lowering Medications http://www.ivf.com/pcostreat.html by Mark Perloe, M.D. INTRODUCTION: Polycystic ovary syndrome is characterized by anovulation (irregular or absent menstrual periods) and hyperandrogenism (elevated serum testosterone and androstenedione). Patients with this syndrome may complain of abnormal bleeding, infertility, obesity, excess hair growth, hair loss and acne. In addition to the clinical and hormonal…
insulin-sensitizing agents
Polycystic ovary syndrome in adolescence.
Semin Reprod Med. 2003 Aug;21(3):301-7 Driscoll DA. Division of Reproductive Genetics, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. Polycystic ovary syndrome (PCOS) is a relatively common disorder among adolescent women. The typical clinical features including menstrual irregularities and hirsutism are usually not apparent until middle to late…
Polycystic ovary syndrome in adolescent girls.
Semin Pediatr Surg. 2005 May;14(2):111-7. Polycystic ovary syndrome in adolescent girls. Pfeifer SM. Division of Reproductive Endocrinology and Infertility, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. Spfeifer@obgyn.upenn.edu Polycystic ovary syndrome (PCOS) has traditionally been thought of as a triad of oligomenorrhea, hirsutism, and obesity. PCOS is now recognized as a heterogeneous disorder…
Troglitazone Improves Ovulation And Hirsutism In Women With Polycystic Ovary Syndrome
April 11, 2001 — Troglitazone Improves Ovulation And Hirsutism In Women With Polycystic Ovary Syndrome A new study, published in the April issue of the Journal of Clinical Endocrinology & Metabolism, shows that troglitazone, an insulin-sensitizing agent and member of the thiazolidinedione class of drugs, improves ovulation and hirsutism in women who suffer from Polycystic…
Chromium Picolinate and PCOS-new study!
New NIH-Funded Pilot Study Indicates Chromium Picolinate Supplementation May be an Effective Treatment for Polycystic Ovarian Syndrome (PCOS) ——————————————————————————– Promising Nutritional Therapy for 2 Million American Women Presented at American Society for Reproductive Medicine Conference (ASRM) San Antonio, TX, October 15, 2003 (Nutrition 21, Inc., Nasdaq: NXXI) — Results of a new pilot study funded…
Insulin and Oral Antidiabetic Agents for Treatment of Polycystic Ovary Syndrome
Insulin and Oral Antidiabetic Agents for Treatment of Polycystic Ovary Syndrome Naci K. Kuscu, MD, and Faik M. Koyuncu, MD Medscape General Medicine 4(4), 2002. © 2002 Medscape Posted 09/13/2002 Abstract Insulin plays a major role in polycystic ovary syndrome (PCOS). Insulin resistance and resultant hyperinsulinemia stimulate both the ovary and adrenal to produce androgens….
Should patients with polycystic ovarian syndrome be treated with metformin?
Should patients with polycystic ovarian syndrome be treated with metformin? A note of cautious optimism Roy Homburg Lis Maternity Hospital, Tel Aviv (Sourasky) Medical Centre, Tel Aviv 64239, Israel (affiliated to the Sackler School of Medicine, Tel Aviv University). E-mail: homburg@netvision.net.il Hyperinsulinaemia has proved to be a key link in the enigmatic generation of the…
Safety and Efficacy of Metformin for PCOS is Still in Question
{kat note: I couldn’t locate the DATE of this article} Safety and Efficacy of Metformin for PCOS is Still in Question A leading British expert says caution is still needed as solid evidence about its efficacy is sparse. The insulin sensitising agent metformin has attracted a lot of attention as a treatment for polycystic ovary…
Metformin’s benefit not limited to obese patients
Metformin’s benefit not limited to obese patients: increases ovulation, decreases testosterone. (Polycystic Ovary Syndrome). Author/s: Timothy F. Kirn Issue: August 1, 2002 SAN FRANCISCO — Metformin significantly increases the frequency of ovulation and decreases circulating testosterone in women with polycystic ovary syndrome who are not obese and have normal indices of insulin sensitivity, Dr. Jean-Patrice…
Toward a new approach: primary and preventive care of the woman with polycystic ovaries
Department of Obstetrics/Gynecology, Oregon Health Sciences University, Portland, Oregon, USA. Polycystic ovarian syndrome (PCOS), characterized by chronic anovulation and hyperandrogenism, affects approximately 5%-10% of reproductive-age women. The reproductive consequences of this syndrome, such as menstrual irregularities and infertility, are well understood and managed by obstetrician/gynecologists. However, less is known about the metabolic consequences of PCOS….
